{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:27:48Z","timestamp":1787113668800,"version":"build-2736575974"},"reference-count":31,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Basal cell carcinoma (BCC) is the most common skin cancer and may negatively influence a patient\u2019s well-being despite low mortality. This systematic review and exploratory meta-analysis evaluated dermatology-related quality of life, as measured exclusively by the Dermatology Life Quality Index (DLQI), in patients with BCC and other non-melanoma skin cancers (NMSC). Instruments other than the DLQI, including disease-specific measures of appearance, scarring, fear of recurrence and treatment satisfaction, were outside the scope of the quantitative synthesis. Methods: A systematic search of the PubMed, Scopus, and the Web of Science was conducted until 5 April 2026 following the PRISMA guidelines. Studies reporting DLQI outcomes in adult patients with BCC, squamous cell carcinoma (SCC), or NMSC were included. Pooled baseline DLQI scores and pre- to post-treatment changes were calculated using a random effects model. Results: Six studies were included. The pooled baseline DLQI score was 3.76 (95% CI: 2.18\u20135.33) in the BCC-only analysis and 4.07 (95% CI: 2.99\u20135.15) in an exploratory expanded analysis including SCC and broader NMSC populations; this estimate should be interpreted as a summary of heterogeneous keratinocyte cancer populations rather than as representative of BCC alone. None of the included studies had an untreated comparator group, so the pre\u2013post results describe the change in DLQI score following treatment rather than a treatment effect. The pooled reduction was 2.38 points (95% CI: 0.56\u20134.19) in the BCC-only and 1.90 points (95% CI: 0.84\u20132.96) in the expanded pre\u2013post analysis. Both fall below the minimal clinically important difference for the DLQI of approximately four points. Heterogeneity was very high throughout (I2 &gt; 95% for baseline analyses), so the pooled means summarize highly dispersed evidence and cannot be read as representative average values. Surgical treatment appeared to show a greater improvement in DLQI scores compared with the single available radiotherapy cohort. This comparison should be interpreted descriptively due to the inclusion of only one radiotherapy study. Conclusions: Patients with BCC and other NMSCs experience measurable impairment in dermatology-related quality of life before treatment, although the overall burden is generally mild. Treatment is associated with improvement in DLQI scores; however, the magnitude of change is modest and may not consistently exceed thresholds considered clinically meaningful. Evidence regarding differences between treatment modalities remains limited, particularly for radiotherapy, and further prospective studies using disease-specific quality-of-life instruments are needed.<\/jats:p>","DOI":"10.3390\/jcm15166351","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:42:17Z","timestamp":1786974137000},"page":"6351","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dermatology-Related Quality of Life Measured with the Dermatology Life Quality Index in Basal Cell Carcinoma and Other Non-Melanoma Skin Cancers: A Systematic Review and Exploratory Meta-Analysis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-2910","authenticated-orcid":false,"given":"Jakub","family":"Nicer","sequence":"first","affiliation":[{"name":"Department of Otolaryngology and Oncological Otolaryngology with Clinical Department of Cranio-Maxillofacial Surgery, Military Institute of Medicine\u2014National Research Institute, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6883-7235","authenticated-orcid":false,"given":"Justyna","family":"Tomaszewska","sequence":"additional","affiliation":[{"name":"Institute of Mathematics and Cryptology, Military University of Technology, 2 Kaliskiego Str., 00-908 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Jurkiewicz","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Oncological Otolaryngology with Clinical Department of Cranio-Maxillofacial Surgery, Military Institute of Medicine\u2014National Research Institute, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7949-1046","authenticated-orcid":false,"given":"Piotr","family":"Rot","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Oncological Otolaryngology with Clinical Department of Cranio-Maxillofacial Surgery, Military Institute of Medicine\u2014National Research Institute, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5105-0687","authenticated-orcid":false,"given":"Maria","family":"Sobol","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Physiology and Pathophysiology, Medical University of Warsaw, 5 Cha\u0142ubi\u0144skiego Str., 02-004 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cpt.2024.08.002","article-title":"Overview of skin cancer types and prevalence rates across continents","volume":"3","author":"Roky","year":"2024","journal-title":"Cancer Pathog. Ther."},{"key":"ref_2","first-page":"A5171","article-title":"Favourable results of Mohs micrographic surgery for basal cell carcinoma","volume":"62","author":"Gniadecki","year":"2015","journal-title":"Dan. Med. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40487-022-00201-8","article-title":"Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management","volume":"10","author":"Naik","year":"2022","journal-title":"Oncol. Ther."},{"key":"ref_4","first-page":"542","article-title":"The incidence and clinical analysis of non-melanoma skin cancer","volume":"36","author":"Lange","year":"2019","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/ddg.14580","article-title":"Known and new facts on basal cell carcinoma","volume":"19","author":"Frischhut","year":"2021","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_6","first-page":"e70850","article-title":"Frederic Mohs: A Trailblazer in Dermatologic Surgery","volume":"16","author":"Pappas","year":"2024","journal-title":"Cureus"},{"key":"ref_7","first-page":"171","article-title":"Treatment of basal cell carcinoma: An overview","volume":"4","author":"Bali","year":"2022","journal-title":"J. Skin Sex. Transm. Dis."},{"key":"ref_8","first-page":"795","article-title":"Do basal cell carcinomas recur after complete conventional surgical excision?","volume":"58","author":"Griffiths","year":"2005","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"ref_9","unstructured":"Siddiqui, F.S., and Leavitt, A. (2026, June 03). Mohs Micrographic Surgery Appropriate Use Criteria, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK603719\/."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"Sup8a","DOI":"10.12968\/jowc.2020.0322","article-title":"Mohs micrographic technique in high-risk basal cell carcinoma: A 3D prediction of safety margins","volume":"33","author":"Cammarata","year":"2024","journal-title":"J. Wound Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ejca.2014.08.018","article-title":"Surgical excision versus Mohs\u2019 micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10-year follow-up","volume":"50","author":"Mosterd","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(08)70260-2","article-title":"Surgical excision versus Mohs\u2019 micrographic surgery for primary and recurrent basal-cell carcinoma of the face: A prospective randomised controlled trial with 5-years\u2019 follow-up","volume":"9","author":"Mosterd","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e13474","DOI":"10.1111\/dth.13474","article-title":"It\u2019s time for Mohs: Micrographic surgery for the treatment of high-risk basal cell carcinomas of the head and neck regions","volume":"33","author":"Dika","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_14","unstructured":"Prickett, K.A., and Ramsey, M.L. (2026, June 03). Mohs Micrographic Surgery, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441833\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/DSS.0000000000000756","article-title":"Direct Cost-Analysis of Mohs Micrographic Surgery and Traditional Excision for Basal Cell Carcinoma at Initial Margin Clearance","volume":"42","author":"Sebaratnam","year":"2016","journal-title":"Dermatol. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1099-1611(200101\/02)10:1<19::AID-PON501>3.0.CO;2-6","article-title":"The prevalence of psychological distress by cancer site","volume":"10","author":"Zabora","year":"2001","journal-title":"Psychooncology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ajd.12205","article-title":"Quality of life in non-melanoma skin cancer","volume":"56","author":"Gaulin","year":"2015","journal-title":"Australas. J. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Karampinis, E., Koumaki, D., Sgouros, D., Nechalioti, P.-M., Toli, O., Pappa, G., Papadakis, M., Georgopoulou, K.-E., Schulze-Roussaki, A.-V., and Kouretas, D. (2025). Non-Melanoma Skin Cancer: Assessing the Systemic Burden of the Disease. Cancers, 17.","DOI":"10.3390\/cancers17040703"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014A simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_20","first-page":"e14094","article-title":"Evaluation of the effect of surgical treatment on quality of life with the Dermatology Life Quality Index in patients with facial nonmelanoma skin cancer","volume":"33","author":"Evrenos","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_21","first-page":"525","article-title":"Skin Cancer and Quality of Life: Assessment With the Dermatology Life Quality Index","volume":"30","author":"Rhee","year":"2004","journal-title":"Dermatol. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s13187-018-1368-y","article-title":"Quality of Life in Patients with Non-melanoma Skin Cancer: Implications for Healthcare Education Services and Supports","volume":"34","author":"Abedini","year":"2019","journal-title":"J. Cancer Educ."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"825095","DOI":"10.1155\/2012\/825095","article-title":"Skin reactions and quality of life after X-ray therapy of basal cell carcinoma","volume":"2012","author":"Skiveren","year":"2012","journal-title":"J. Skin Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00434740","article-title":"Basal cell carcinomas cause little handicap","volume":"5","author":"Blackford","year":"1996","journal-title":"Qual. Life Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8900","DOI":"10.1038\/s41598-024-53457-7","article-title":"Using optical coherence tomography to optimize Mohs micrographic surgery","volume":"14","author":"Akella","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Popescu, C., Iliescu, C.A., Truica, A.M., Popa, L.G., Porosnicu, A.L., Tudose, I., Boeru, C., and Popescu, M.N. (2026). From Ultrasound to Histopathology: Agreement Analysis and Depth Correction Model for Basal Cell Carcinoma Using a Portable 20 MHz High-Frequency Ultrasound Device. Diagnostics, 16.","DOI":"10.3390\/diagnostics16070978"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100022","DOI":"10.1016\/j.ejcskn.2024.100022","article-title":"Quality of life issues faced by patients with keratinocyte cancer: A systematic review","volume":"2","author":"Kennedy","year":"2024","journal-title":"EJC Skin Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Stundys, D., Ulianskaite, G., Stundiene, I., Grigaitiene, J., and Jancoriene, L. (2023). The Quality of Life in Surgically Treated Head and Neck Basal Cell Carcinoma Patients: A Comprehensive Review. Cancers, 15.","DOI":"10.3390\/cancers15030801"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"21739","DOI":"10.1038\/s41598-024-67740-0","article-title":"The impact of basal cell carcinoma on the quality-of-life in older patients","volume":"14","author":"Meertens","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaad.2025.03.022","article-title":"Patient-reported quality of life and aesthetic satisfaction continues to improve for 1 year after Mohs surgery: A multicenter prospective cohort study","volume":"93","author":"Veldhuizen","year":"2025","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6351\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:17:04Z","timestamp":1787113024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":31,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166351"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166351","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}